[
  {
    "title": "康恩贝：布洛芬颗粒日产120万袋 防疫产品产能再上新台阶",
    "href": "http://stock.jrj.com.cn/2023/01/02084537252739.shtml",
    "datetime": "2023-01-02 08:45:59",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：黄蜀葵花总黄酮提取物及口腔贴片获批上市",
    "href": "http://stock.jrj.com.cn/2022/12/22164337231631.shtml",
    "datetime": "2022-12-22 16:43:55",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：子公司乙酰半胱氨酸颗粒获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/11/22164937157719.shtml",
    "datetime": "2022-11-22 16:49:52",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：向537名激励对象授予6247.5万份股票期权",
    "href": "http://stock.jrj.com.cn/2022/11/10221437129275.shtml",
    "datetime": "2022-11-10 22:14:42",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：第三季度净利1693.92万元 同比扭亏",
    "href": "http://stock.jrj.com.cn/2022/10/25193737082819.shtml",
    "datetime": "2022-10-25 19:37:51",
    "code": "600572"
  },
  {
    "title": "康恩贝：拟受让中医药大学饮片公司51%股权",
    "href": "http://stock.jrj.com.cn/2022/09/29095637029976.shtml",
    "datetime": "2022-09-29 09:56:28",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：拟以1.698亿元受让中医药大学饮片公司51%股权",
    "href": "http://stock.jrj.com.cn/2022/09/28165437027876.shtml",
    "datetime": "2022-09-28 16:54:45",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：股东胡季强质押5355.508万股和解质5083万股",
    "href": "http://stock.jrj.com.cn/2022/09/22170537014457.shtml",
    "datetime": "2022-09-22 17:05:09",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：拟注册发行不超10亿元超短期融资券和不超10亿元中期票据",
    "href": "http://stock.jrj.com.cn/2022/09/15180436997857.shtml",
    "datetime": "2022-09-15 18:04:05",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：拟推7000万份的2022年股票期权激励计划",
    "href": "http://stock.jrj.com.cn/2022/09/15180236997861.shtml",
    "datetime": "2022-09-15 18:02:43",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：拟以3558万元受让奥托康科技公司100%股权",
    "href": "http://stock.jrj.com.cn/2022/08/24181836931373.shtml",
    "datetime": "2022-08-24 18:18:58",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：金华康恩贝的EVT-401片药物临床试验获批",
    "href": "http://stock.jrj.com.cn/2022/08/24181736931374.shtml",
    "datetime": "2022-08-24 18:17:25",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：上半年净利润降14.96%至2.09亿元",
    "href": "http://stock.jrj.com.cn/2022/08/24181436931378.shtml",
    "datetime": "2022-08-24 18:14:26",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：贵州拜特公司拟以不低于1.21亿元挂牌转让部分土地使用权和厂房等资产",
    "href": "http://stock.jrj.com.cn/2022/08/11170836891082.shtml",
    "datetime": "2022-08-11 17:08:01",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：完成兑付本息2.03亿元超短期融资券",
    "href": "http://stock.jrj.com.cn/2022/07/05160036783606.shtml",
    "datetime": "2022-07-05 16:00:17",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：2021年度权益分派10派1.6元 股权登记日为6月28日",
    "href": "http://stock.jrj.com.cn/2022/06/22155236749666.shtml",
    "datetime": "2022-06-22 15:52:48",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：子公司黄蜀葵花总黄酮提取物及口腔贴片药品注册获受理",
    "href": "http://stock.jrj.com.cn/2022/06/16161436734736.shtml",
    "datetime": "2022-06-16 16:14:30",
    "code": "600572"
  },
  {
    "title": "康恩贝控股股东省健康产业集团增持231.3万股 耗资1010.06万 2021年公司净利20.09亿",
    "href": "http://stock.jrj.com.cn/2022/05/31183236693989.shtml",
    "datetime": "2022-05-31 18:32:48",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：康恩贝集团完成增持233.38万股 共耗资1010.92万元",
    "href": "http://stock.jrj.com.cn/2022/05/31170236693532.shtml",
    "datetime": "2022-05-31 17:02:05",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：控股股东完成增持231.30万股 共耗资1010.06万元",
    "href": "http://stock.jrj.com.cn/2022/05/31165936693471.shtml",
    "datetime": "2022-05-31 16:59:54",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：拟以不超4.5亿元认购英特集团非公开发行股票",
    "href": "http://stock.jrj.com.cn/2022/05/25175836678190.shtml",
    "datetime": "2022-05-25 17:58:09",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)与浙江中医药大学签订战略合作协议",
    "href": "http://stock.jrj.com.cn/2022/05/05171536570299.shtml",
    "datetime": "2022-05-05 17:15:31",
    "code": "600572"
  },
  {
    "title": "康恩贝2022年第一季度净利1.02亿同比增长112.25% 处方药产品销售收入增长",
    "href": "http://stock.jrj.com.cn/2022/05/03185036546070.shtml",
    "datetime": "2022-05-03 18:50:45",
    "code": "600572"
  },
  {
    "title": "A股异动 | 康恩贝(600572.SH)涨超4% 去年净利大增3.4倍",
    "href": "http://stock.jrj.com.cn/2022/04/22095436426548.shtml",
    "datetime": "2022-04-22 09:54:19",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：2021年净利增343.24%至20.09亿元 拟10派1.6元",
    "href": "http://stock.jrj.com.cn/2022/04/21184036420649.shtml",
    "datetime": "2022-04-21 18:40:08",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：杭州康恩贝的铝碳酸镁咀嚼片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/04/20171036410688.shtml",
    "datetime": "2022-04-20 17:10:57",
    "code": "600572"
  },
  {
    "title": "康恩贝2022年第一季度预计净利9600万-1.05亿 同比增加100%-120%加快发展线上新零售",
    "href": "http://stock.jrj.com.cn/2022/04/06183036263742.shtml",
    "datetime": "2022-04-06 18:30:42",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：注射用泮托拉唑钠通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/03/21163434855923.shtml",
    "datetime": "2022-03-21 16:34:49",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：康恩贝集团已合计增持233.38万股",
    "href": "http://stock.jrj.com.cn/2022/03/08160234541303.shtml",
    "datetime": "2022-03-08 16:02:02",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：迪耳药业25%股权由海南亚洲制药以3577.25万元摘牌",
    "href": "http://stock.jrj.com.cn/2022/02/07180934302493.shtml",
    "datetime": "2022-02-07 18:09:04",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：金华康恩贝10mg和20mg规格的奥美拉唑肠溶胶囊通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/01/24165234204789.shtml",
    "datetime": "2022-01-24 16:52:10",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：子公司药品注射用帕瑞昔布钠通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/01/17165334165062.shtml",
    "datetime": "2022-01-17 16:53:35",
    "code": "600572"
  },
  {
    "title": "康恩贝2021年预计净利19.28亿-21.53亿 同比增加325%-375%",
    "href": "http://stock.jrj.com.cn/2022/01/13184834155114.shtml",
    "datetime": "2022-01-13 18:48:32",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：2021年度净利预增325%-375%",
    "href": "http://stock.jrj.com.cn/2022/01/13165034154430.shtml",
    "datetime": "2022-01-13 16:50:56",
    "code": "600572"
  },
  {
    "title": "康臣药业(01681.HK)与康恩贝订立战略合作框架协议",
    "href": "http://stock.jrj.com.cn/2022/01/07185534134530.shtml",
    "datetime": "2022-01-07 18:55:18",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：与康臣药业集团签订战略合作框架协议",
    "href": "http://stock.jrj.com.cn/2022/01/07162534133701.shtml",
    "datetime": "2022-01-07 16:25:43",
    "code": "600572"
  },
  {
    "title": "康恩贝发行2亿短期融资券 票面利率2.8%",
    "href": "http://stock.jrj.com.cn/2022/01/06200434130890.shtml",
    "datetime": "2022-01-06 20:04:04",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：完成发行2亿元的2022年度第一期超短期融资券(乡村振兴)",
    "href": "http://stock.jrj.com.cn/2022/01/06193634130669.shtml",
    "datetime": "2022-01-06 19:36:01",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：子公司金华康恩贝拟受托管理奥托康公司",
    "href": "http://stock.jrj.com.cn/2021/12/30165634087122.shtml",
    "datetime": "2021-12-30 16:56:21",
    "code": "600572"
  },
  {
    "title": "A股异动 | 康恩贝(600572.SH)触及涨停 银杏叶产品拟中标集采",
    "href": "http://stock.jrj.com.cn/2021/12/24141534057276.shtml",
    "datetime": "2021-12-24 14:15:46",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：银杏叶产品拟中标中成药省际联盟集中带量采购",
    "href": "http://stock.jrj.com.cn/2021/12/23163734052959.shtml",
    "datetime": "2021-12-23 16:37:19",
    "code": "600572"
  },
  {
    "title": "康恩贝与1药网签署战略合作协议 共拓院外市场新蓝海",
    "href": "http://stock.jrj.com.cn/2021/12/21193134042882.shtml",
    "datetime": "2021-12-21 19:31:16",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：挂牌转让贵州拜特公司100%股权仍未征集到合格意向受让方 拟予以撤牌",
    "href": "http://stock.jrj.com.cn/2021/12/20164934034849.shtml",
    "datetime": "2021-12-20 16:49:17",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：省中医药健康产业集团已增持123万股 增持金额已超最低金额50%",
    "href": "http://stock.jrj.com.cn/2021/12/09180633990807.shtml",
    "datetime": "2021-12-09 18:06:43",
    "code": "600572"
  },
  {
    "title": "康恩贝16.8亿出售珍视明42%股权 将增利23亿聚焦中药大健康产业",
    "href": "http://stock.jrj.com.cn/2021/12/09074233988312.shtml",
    "datetime": "2021-12-09 07:42:13",
    "code": "600572"
  },
  {
    "title": "康恩贝拟16.8亿转让珍视明股权 或将增利23亿改善流动性",
    "href": "http://stock.jrj.com.cn/2021/12/08163533985058.shtml",
    "datetime": "2021-12-08 16:35:40",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：就挂牌转让珍视明公司42%股权 意向受让方为由Fortunate Gem等5家公司组成的联合体",
    "href": "http://stock.jrj.com.cn/2021/12/07180933980914.shtml",
    "datetime": "2021-12-07 18:09:21",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：康恩贝集团已增持126.88万股 增持金额已达最低金额50%",
    "href": "http://stock.jrj.com.cn/2021/12/02165033955722.shtml",
    "datetime": "2021-12-02 16:50:31",
    "code": "600572"
  },
  {
    "title": "康恩贝董监高及核心管理人员合计增持65.5万股 耗资272.48万 第三季度公司亏损3091.02万",
    "href": "http://stock.jrj.com.cn/2021/11/30183233945188.shtml",
    "datetime": "2021-11-30 18:32:13",
    "code": "600572"
  },
  {
    "title": "康恩贝：控股股东及康恩贝集团计划增持公司股份",
    "href": "http://stock.jrj.com.cn/2021/11/30163933944455.shtml",
    "datetime": "2021-11-30 16:39:33",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：部分董监高及核心管理人员合计增持65.5万股",
    "href": "http://stock.jrj.com.cn/2021/11/30162833944399.shtml",
    "datetime": "2021-11-30 16:28:46",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：康恩贝集团拟增持1000万元-1亿元的公司股份",
    "href": "http://stock.jrj.com.cn/2021/11/30162733944397.shtml",
    "datetime": "2021-11-30 16:27:44",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：控股股东拟增持1000万元-2亿元的公司股份",
    "href": "http://stock.jrj.com.cn/2021/11/30162633944393.shtml",
    "datetime": "2021-11-30 16:26:09",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：控股子公司拟挂牌转让迪耳药业25%股权",
    "href": "http://stock.jrj.com.cn/2021/11/29171133938441.shtml",
    "datetime": "2021-11-29 17:11:32",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：一致行动人博康医药解质及质押575万股",
    "href": "http://stock.jrj.com.cn/2021/11/25165233919232.shtml",
    "datetime": "2021-11-25 16:52:48",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：盐酸吡格列酮片通过仿制药质量和疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2021/10/20162133721970.shtml",
    "datetime": "2021-10-20 16:21:27",
    "code": "600572"
  },
  {
    "title": "昔日“利润奶牛”再遭甩卖，康恩贝想打什么牌？",
    "href": "http://stock.jrj.com.cn/2021/10/12081833677078.shtml",
    "datetime": "2021-10-12 08:18:10",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：拟挂牌转让珍视明公司42%股权",
    "href": "http://stock.jrj.com.cn/2021/09/29222033538744.shtml",
    "datetime": "2021-09-29 22:20:04",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：拟挂牌转让贵州拜特公司100%股权",
    "href": "http://stock.jrj.com.cn/2021/09/29221833538734.shtml",
    "datetime": "2021-09-29 22:18:09",
    "code": "600572"
  },
  {
    "title": "康恩贝副董事长罗国良辞职 选举应春晓为公司副董事长 上半年公司净利2.46亿",
    "href": "http://stock.jrj.com.cn/2021/09/29214433538589.shtml",
    "datetime": "2021-09-29 21:44:22",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：持股5%以上的胡季强质押5300万股及解质4200万股",
    "href": "http://stock.jrj.com.cn/2021/09/27165133524278.shtml",
    "datetime": "2021-09-27 16:51:24",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：拟挂牌转让珍视明公司42%股权",
    "href": "http://stock.jrj.com.cn/2021/09/22201033500140.shtml",
    "datetime": "2021-09-22 20:10:34",
    "code": "600572"
  },
  {
    "title": "康恩贝：子公司拟1亿元受让黄蜀葵花总黄酮提取物及口腔贴片相关权益",
    "href": "http://stock.jrj.com.cn/2021/09/15163233439917.shtml",
    "datetime": "2021-09-15 16:32:37",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：子公司拟受让黄蜀葵花总黄酮提取物及口腔贴片相关权益",
    "href": "http://stock.jrj.com.cn/2021/09/13174933429129.shtml",
    "datetime": "2021-09-13 17:49:52",
    "code": "600572"
  },
  {
    "title": "康恩贝：业绩降近五成，股价持续低迷",
    "href": "http://stock.jrj.com.cn/2021/08/14103233252266.shtml",
    "datetime": "2021-08-14 10:32:43",
    "code": "600572"
  },
  {
    "title": "康恩贝2021年半年度净利2.46亿元 同比净利减少49.20%",
    "href": "http://stock.jrj.com.cn/2021/08/12182433243945.shtml",
    "datetime": "2021-08-12 18:24:27",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：拟挂牌转让贵州拜特公司100%股权",
    "href": "http://stock.jrj.com.cn/2021/08/12173033243547.shtml",
    "datetime": "2021-08-12 17:30:40",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)上半年扣非净利升124.36%至2.46亿元",
    "href": "http://stock.jrj.com.cn/2021/08/12171733243462.shtml",
    "datetime": "2021-08-12 17:17:19",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：就挂牌转让兰信小贷公司30%股权 由关联方公开摘牌受让",
    "href": "http://stock.jrj.com.cn/2021/08/05221833209355.shtml",
    "datetime": "2021-08-05 22:18:51",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：甲钴胺片通过仿制药质量和疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2021/08/02165633189582.shtml",
    "datetime": "2021-08-02 16:56:47",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：子公司的单剂量包装玻璃酸钠滴眼液获批上市",
    "href": "http://stock.jrj.com.cn/2021/07/08162533064480.shtml",
    "datetime": "2021-07-08 16:25:59",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：利伐沙班片(10mg)拟中标第五批国家组织药品集采",
    "href": "http://stock.jrj.com.cn/2021/06/23185932984298.shtml",
    "datetime": "2021-06-23 18:59:21",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：注射用奥美拉唑钠通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/06/17172932948341.shtml",
    "datetime": "2021-06-17 17:29:24",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：以不低于5337万元挂牌转让兰信小贷公司30%股权",
    "href": "http://stock.jrj.com.cn/2021/06/11173632912220.shtml",
    "datetime": "2021-06-11 17:36:09",
    "code": "600572"
  },
  {
    "title": "康恩贝：目前已基本消化了贵州拜特公司减收减利对业绩的巨大冲击",
    "href": "http://stock.jrj.com.cn/2021/06/08063532889788.shtml",
    "datetime": "2021-06-08 06:35:24",
    "code": "600572"
  },
  {
    "title": "康恩贝：不存在所称公司控股股东的变更过程中有损害公司中小股东利益的情形",
    "href": "http://stock.jrj.com.cn/2021/06/07221032889207.shtml",
    "datetime": "2021-06-07 22:10:36",
    "code": "600572"
  },
  {
    "title": "康恩贝：公司将重点围绕公司核心业务创新和市场创新持续加大研发投入",
    "href": "http://stock.jrj.com.cn/2021/06/07212132888942.shtml",
    "datetime": "2021-06-07 21:21:58",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：收到及预计收到政府补助4535.33万元",
    "href": "http://stock.jrj.com.cn/2021/05/24164632811015.shtml",
    "datetime": "2021-05-24 16:46:04",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：草酸艾司西酞普兰片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/05/14174132755996.shtml",
    "datetime": "2021-05-14 17:41:58",
    "code": "600572"
  },
  {
    "title": "康恩贝2021年第一季度净利4784万下滑74% 自我保健产品业务销售收入下降",
    "href": "http://stock.jrj.com.cn/2021/04/24180932435465.shtml",
    "datetime": "2021-04-24 18:09:56",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：一季度净利降73.76%至4783.73万元",
    "href": "http://stock.jrj.com.cn/2021/04/23173832430876.shtml",
    "datetime": "2021-04-23 17:38:42",
    "code": "600572"
  },
  {
    "title": "康恩贝2020年净利4.53亿扭亏为盈销售费用下降 董事长胡季强薪酬84.59万",
    "href": "http://stock.jrj.com.cn/2021/04/21185832417752.shtml",
    "datetime": "2021-04-21 18:58:18",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：金华康恩贝利伐沙班片获批上市",
    "href": "http://stock.jrj.com.cn/2021/03/24171232209319.shtml",
    "datetime": "2021-03-24 17:12:12",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：1mg规格非那雄胺片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/03/24171032209302.shtml",
    "datetime": "2021-03-24 17:10:07",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：2020年实际已经收到及预计收到与收益相关的政府补助9151万元",
    "href": "http://stock.jrj.com.cn/2021/02/26165632033543.shtml",
    "datetime": "2021-02-26 16:56:28",
    "code": "600572"
  },
  {
    "title": "康恩贝：预计公司2020年实现归母净利润为4亿元至4.8亿元",
    "href": "http://stock.jrj.com.cn/2021/02/04155731848914.shtml",
    "datetime": "2021-02-04 15:57:43",
    "code": "600572"
  },
  {
    "title": "康恩贝：公司旗下子公司品牌珍视明分别与李佳琦、薇娅等一线网红主播进行合作",
    "href": "http://stock.jrj.com.cn/2021/02/04155331848879.shtml",
    "datetime": "2021-02-04 15:53:17",
    "code": "600572"
  },
  {
    "title": "康恩贝：公司的控股子公司江西珍视明药业有限公司是一家专业从事眼科产品研发、生产、销售的现代制药企业",
    "href": "http://stock.jrj.com.cn/2021/02/04154631848846.shtml",
    "datetime": "2021-02-04 15:46:10",
    "code": "600572"
  },
  {
    "title": "康恩贝：公司目前已有的大健康产品主要包括眼部护理等眼健康产品和保健品及功能性食品等产品",
    "href": "http://stock.jrj.com.cn/2021/02/04154631848847.shtml",
    "datetime": "2021-02-04 15:46:09",
    "code": "600572"
  },
  {
    "title": "康恩贝两款产品拟中标第四批国家药品集采 将对公司未来业绩产生积极影响",
    "href": "http://stock.jrj.com.cn/2021/02/03205831845124.shtml",
    "datetime": "2021-02-03 20:58:21",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：股东胡季强拟协议转让1.59%股份予康恩贝集团公司",
    "href": "http://stock.jrj.com.cn/2021/01/22172931745964.shtml",
    "datetime": "2021-01-22 17:29:18",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：布洛芬颗粒通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/01/18171831716011.shtml",
    "datetime": "2021-01-18 17:18:19",
    "code": "600572"
  },
  {
    "title": "加快发展线上新零售业务等原因 康恩贝预计2020年业绩扭亏为盈",
    "href": "http://stock.jrj.com.cn/2021/01/18111331713926.shtml",
    "datetime": "2021-01-18 11:13:43",
    "code": "600572"
  },
  {
    "title": "康恩贝2020年预计净利4亿-4.8亿 线上新零售业务加快发展",
    "href": "http://stock.jrj.com.cn/2021/01/15193531700885.shtml",
    "datetime": "2021-01-15 19:35:40",
    "code": "600572"
  },
  {
    "title": "康恩贝：调整业务结构、消化不利因素 2020年业绩预计实现修复增长",
    "href": "http://stock.jrj.com.cn/2021/01/15184731700663.shtml",
    "datetime": "2021-01-15 18:47:21",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)2020年度预盈4亿-4.8亿元 同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2021/01/15164131699154.shtml",
    "datetime": "2021-01-15 16:41:59",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：盐酸氨溴索注射液通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/01/12170431677159.shtml",
    "datetime": "2021-01-12 17:04:29",
    "code": "600572"
  },
  {
    "title": "康恩贝(600572.SH)：2个药品新增调入2020版国家医保目录",
    "href": "http://stock.jrj.com.cn/2020/12/28190531587868.shtml",
    "datetime": "2020-12-28 19:05:47",
    "code": "600572"
  },
  {
    "title": "康恩贝：2020年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/10/28001231145581.shtml",
    "datetime": "2020-10-28 00:12:53",
    "code": "600572"
  },
  {
    "title": "康恩贝股东胡季强质押6300万股",
    "href": "http://stock.jrj.com.cn/2020/10/23210131118992.shtml",
    "datetime": "2020-10-23 21:01:06",
    "code": "600572"
  },
  {
    "title": "浙江核查处置15批次不合格食品 康恩贝永辉超市登榜",
    "href": "http://stock.jrj.com.cn/2020/10/14174931052627.shtml",
    "datetime": "2020-10-14 17:49:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：参股企业嘉和生物成功登陆港交所",
    "href": "http://stock.jrj.com.cn/2020/10/09214131012597.shtml",
    "datetime": "2020-10-09 21:41:56",
    "code": "600572"
  },
  {
    "title": "康恩贝：比如云南白药、片仔癀等公司已成行业标杆",
    "href": "http://stock.jrj.com.cn/2020/09/15164830755853.shtml",
    "datetime": "2020-09-15 16:48:07",
    "code": "600572"
  },
  {
    "title": "康恩贝2020年上半年净利4.83亿增长24.03% 销售费用同比下滑",
    "href": "http://stock.jrj.com.cn/2020/08/21102330555757.shtml",
    "datetime": "2020-08-21 10:23:15",
    "code": "600572"
  },
  {
    "title": "康恩贝上半年营业收入32亿元 同比减少12.30%",
    "href": "http://stock.jrj.com.cn/2020/07/21075630300956.shtml",
    "datetime": "2020-07-21 07:56:00",
    "code": "600572"
  },
  {
    "title": "康恩贝2020年上半年净利4.85亿增长24% 子公司丹参川芎嗪注射液销售下降",
    "href": "http://stock.jrj.com.cn/2020/07/20202930295426.shtml",
    "datetime": "2020-07-20 20:29:47",
    "code": "600572"
  },
  {
    "title": "康恩贝泮托拉唑钠肠溶片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/07/14195430240930.shtml",
    "datetime": "2020-07-14 19:54:59",
    "code": "600572"
  },
  {
    "title": "康恩贝董事长兼副总裁王如伟辞职 2019年薪酬为124.24万元",
    "href": "http://stock.jrj.com.cn/2020/07/01185330112985.shtml",
    "datetime": "2020-07-01 18:53:12",
    "code": "600572"
  },
  {
    "title": "康恩贝副董事长兼副总裁王如伟因个人原因辞职",
    "href": "http://stock.jrj.com.cn/2020/06/29195630088875.shtml",
    "datetime": "2020-06-29 19:56:00",
    "code": "600572"
  },
  {
    "title": "康恩贝副董事长兼副总裁王如伟辞职 2019年薪酬为124.24万元",
    "href": "http://stock.jrj.com.cn/2020/06/29190330088557.shtml",
    "datetime": "2020-06-29 19:03:39",
    "code": "600572"
  },
  {
    "title": "康恩贝复方磺胺甲噁唑片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2020/06/23183130000577.shtml",
    "datetime": "2020-06-23 18:31:31",
    "code": "600572"
  },
  {
    "title": "康恩贝：公司产品抽检不合格 尚未发生损失、赔偿等情况",
    "href": "http://stock.jrj.com.cn/2020/06/16184229939735.shtml",
    "datetime": "2020-06-16 18:42:03",
    "code": "600572"
  },
  {
    "title": "浙江康恩贝秦皮抽查不合规 登浙江药品质量检验公告",
    "href": "http://stock.jrj.com.cn/2020/06/16112829936172.shtml",
    "datetime": "2020-06-16 11:28:00",
    "code": "600572"
  },
  {
    "title": "康恩贝终止参与投资设立健康产业基金",
    "href": "http://stock.jrj.com.cn/2020/06/01211529817803.shtml",
    "datetime": "2020-06-01 21:15:44",
    "code": "600572"
  },
  {
    "title": "控股股东拟转让5.34亿股浙江国资委将成康恩贝新实控人",
    "href": "http://stock.jrj.com.cn/2020/05/30020929799823.shtml",
    "datetime": "2020-05-30 02:09:28",
    "code": "600572"
  },
  {
    "title": "康恩贝：控股股东拟向省中医药健康产业集团转让公司总股本20%",
    "href": "http://stock.jrj.com.cn/2020/05/29205529798322.shtml",
    "datetime": "2020-05-29 20:55:40",
    "code": "600572"
  },
  {
    "title": "康恩贝：控股股东拟向省中医药健康产业集团转让公司总股本20% 实际控制人变更为浙江省国资委",
    "href": "http://stock.jrj.com.cn/2020/05/29171929796850.shtml",
    "datetime": "2020-05-29 17:19:59",
    "code": "600572"
  },
  {
    "title": "全国人大代表、康恩贝董事长胡季强：加快制订医疗保障法 防疫相关法律需完善",
    "href": "http://stock.jrj.com.cn/2020/05/27144329778671.shtml",
    "datetime": "2020-05-27 14:43:11",
    "code": "600572"
  },
  {
    "title": "全国人大代表、康恩贝董事长胡季强：完善法律条文 提高医疗保障水平",
    "href": "http://stock.jrj.com.cn/2020/05/27074629775554.shtml",
    "datetime": "2020-05-27 07:46:12",
    "code": "600572"
  },
  {
    "title": "康恩贝：2019年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2020/05/19073029708282.shtml",
    "datetime": "2020-05-19 07:30:02",
    "code": "600572"
  },
  {
    "title": "康恩贝：进一步聚焦中药大健康业务发展 推动“两大工程”建设",
    "href": "http://stock.jrj.com.cn/2020/05/06164229599826.shtml",
    "datetime": "2020-05-06 16:42:00",
    "code": "600572"
  },
  {
    "title": "康恩贝第一季度盈利1.82亿 较上年同期增长2.20%",
    "href": "http://stock.jrj.com.cn/2020/05/01192029441013.shtml",
    "datetime": "2020-05-01 19:20:46",
    "code": "600572"
  },
  {
    "title": "康恩贝2019年亏损3.46亿元 市场销售量和收入出现较大幅度下滑",
    "href": "http://stock.jrj.com.cn/2020/04/29104129416907.shtml",
    "datetime": "2020-04-29 10:41:05",
    "code": "600572"
  },
  {
    "title": "康恩贝2019年亏损3.46亿由盈转亏 丹参川芎嗪注射液销量大幅下滑",
    "href": "http://stock.jrj.com.cn/2020/04/28194029407024.shtml",
    "datetime": "2020-04-28 19:40:26",
    "code": "600572"
  },
  {
    "title": "康恩贝：2019年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/04/28155029404938.shtml",
    "datetime": "2020-04-28 15:50:12",
    "code": "600572"
  },
  {
    "title": "康恩贝：2020年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/04/28155029404939.shtml",
    "datetime": "2020-04-28 15:50:12",
    "code": "600572"
  },
  {
    "title": "康恩贝：关于召开2019年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/04/28155029404937.shtml",
    "datetime": "2020-04-28 15:50:12",
    "code": "600572"
  },
  {
    "title": "康恩贝：九届董事会第七次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/04/28155029404940.shtml",
    "datetime": "2020-04-28 15:50:12",
    "code": "600572"
  },
  {
    "title": "康恩贝：2019年亏损3.46亿元 今年一季度实现盈利",
    "href": "http://stock.jrj.com.cn/2020/04/28111629402836.shtml",
    "datetime": "2020-04-28 11:16:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：子公司玻璃酸钠滴眼液获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/04/20214229331706.shtml",
    "datetime": "2020-04-20 21:42:10",
    "code": "600572"
  },
  {
    "title": "康恩贝：子公司玻璃酸钠滴眼液获药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/04/20171029329970.shtml",
    "datetime": "2020-04-20 17:10:00",
    "code": "600572"
  },
  {
    "title": "变更部分募资用途 康恩贝加码原料药供应",
    "href": "http://stock.jrj.com.cn/2020/04/19210129321220.shtml",
    "datetime": "2020-04-19 21:01:26",
    "code": "600572"
  },
  {
    "title": "康恩贝聘任袁振贤为公司副总裁",
    "href": "http://stock.jrj.com.cn/2020/04/14200929285916.shtml",
    "datetime": "2020-04-14 20:09:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：2020年第一季度业绩预告",
    "href": "http://stock.jrj.com.cn/2020/04/08010029229073.shtml",
    "datetime": "2020-04-08 01:00:29",
    "code": "600572"
  },
  {
    "title": "康恩贝：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/07225029228644.shtml",
    "datetime": "2020-04-07 22:50:00",
    "code": "600572"
  },
  {
    "title": "康恩贝拟易主后 预计一季度净利润增长0-10%",
    "href": "http://stock.jrj.com.cn/2020/04/07215929228398.shtml",
    "datetime": "2020-04-07 21:59:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：预计一季度净利润同比增长3.1%-4.5%",
    "href": "http://stock.jrj.com.cn/2020/04/07204529228041.shtml",
    "datetime": "2020-04-07 20:45:00",
    "code": "600572"
  },
  {
    "title": "康恩贝2020年一季度预计净利同比增加0万元到1760万元",
    "href": "http://stock.jrj.com.cn/2020/04/07202229227872.shtml",
    "datetime": "2020-04-07 20:22:40",
    "code": "600572"
  },
  {
    "title": "康恩贝：一季度净利预增0%-10% 非那雄胺片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/04/07184129227343.shtml",
    "datetime": "2020-04-07 18:41:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：浙江省国资委旗下公司拟受让20%股权 实控人将变更",
    "href": "http://stock.jrj.com.cn/2020/04/03092929184723.shtml",
    "datetime": "2020-04-03 09:29:00",
    "code": "600572"
  },
  {
    "title": "浙江省国贸集团拟入主康恩贝 合建省中医药健康产业主平台",
    "href": "http://stock.jrj.com.cn/2020/04/02230229180088.shtml",
    "datetime": "2020-04-02 23:02:00",
    "code": "600572"
  },
  {
    "title": "康恩贝实控人将变更为浙江省国资委",
    "href": "http://stock.jrj.com.cn/2020/04/02221429179823.shtml",
    "datetime": "2020-04-02 22:14:40",
    "code": "600572"
  },
  {
    "title": "康恩贝：控股股东转让20%股份 公司实控人拟变更为浙江省国资委",
    "href": "http://stock.jrj.com.cn/2020/04/02212929179539.shtml",
    "datetime": "2020-04-02 21:29:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：布洛芬颗粒通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/03/20172529070198.shtml",
    "datetime": "2020-03-20 17:25:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：九届董事会2020年第二次临时会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/03/19221029063756.shtml",
    "datetime": "2020-03-19 22:10:53",
    "code": "600572"
  },
  {
    "title": "中国新冠病毒检测试剂盒驰援海外抗疫 康恩贝等13家上市公司在列",
    "href": "http://stock.jrj.com.cn/2020/03/19204129063244.shtml",
    "datetime": "2020-03-19 20:41:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：开发高端产品 应对国际市场CBD价格下跌",
    "href": "http://stock.jrj.com.cn/2020/03/03134228944072.shtml",
    "datetime": "2020-03-03 13:42:00",
    "code": "600572"
  },
  {
    "title": "康恩贝与喜鹊医药签订战略合作框架协议",
    "href": "http://stock.jrj.com.cn/2020/02/26214428899780.shtml",
    "datetime": "2020-02-26 21:44:19",
    "code": "600572"
  },
  {
    "title": "浙江首单疫情防控债 康恩贝拟发行3-5亿元超短融",
    "href": "http://stock.jrj.com.cn/2020/02/13211628825718.shtml",
    "datetime": "2020-02-13 21:16:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：五药品被列入浙江临时性抗“疫”采购目录",
    "href": "http://stock.jrj.com.cn/2020/02/13092728821405.shtml",
    "datetime": "2020-02-13 09:27:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：公司及下属主要企业已全面进入复工复产模式",
    "href": "http://stock.jrj.com.cn/2020/02/11084528807051.shtml",
    "datetime": "2020-02-11 08:45:34",
    "code": "600572"
  },
  {
    "title": "康恩贝：公司及下属主要企业已全面进入复工复产模式",
    "href": "http://stock.jrj.com.cn/2020/02/11084228807039.shtml",
    "datetime": "2020-02-11 08:42:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：盐酸坦索罗辛缓释胶囊通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/02/10155428803332.shtml",
    "datetime": "2020-02-10 15:54:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：子公司药品通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/02/10154828803297.shtml",
    "datetime": "2020-02-10 15:48:29",
    "code": "600572"
  },
  {
    "title": "康恩贝旗下两家企业获批消毒产品生产卫生许可",
    "href": "http://stock.jrj.com.cn/2020/02/09213128798767.shtml",
    "datetime": "2020-02-09 21:31:00",
    "code": "600572"
  },
  {
    "title": "地方增加的抗疫药涉及16家公司 上海凯宝、康恩贝入选的是大品种",
    "href": "http://stock.jrj.com.cn/2020/02/06171528784709.shtml",
    "datetime": "2020-02-06 17:15:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：政策利空致2019年预亏 轻装上阵有望实现逆转",
    "href": "http://stock.jrj.com.cn/2020/02/05224228778532.shtml",
    "datetime": "2020-02-05 22:42:26",
    "code": "600572"
  },
  {
    "title": "康恩贝：捐赠逾2300万元医药物资抗击疫情 主打产品与协和医院方剂“不谋而合”",
    "href": "http://stock.jrj.com.cn/2020/02/05223928778522.shtml",
    "datetime": "2020-02-05 22:39:39",
    "code": "600572"
  },
  {
    "title": "康恩贝：雷神山、火神山两家医院要求公司确保每月1.8万盒乙酰半胱氨酸泡腾片供应备货",
    "href": "http://stock.jrj.com.cn/2020/02/05213928778323.shtml",
    "datetime": "2020-02-05 21:39:25",
    "code": "600572"
  },
  {
    "title": "康恩贝集团及上市公司捐赠复方鱼腥草合剂等产品及疫情防控用品",
    "href": "http://stock.jrj.com.cn/2020/02/05190328777689.shtml",
    "datetime": "2020-02-05 19:03:00",
    "code": "600572"
  },
  {
    "title": "李兰娟说的两个药产业链上有哪些公司？“两座山”医院紧急采购康恩贝药品",
    "href": "http://stock.jrj.com.cn/2020/02/04221328769302.shtml",
    "datetime": "2020-02-04 22:13:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：捐赠逾2300万元医药物资抗击疫情 主打产品与协和医院方剂“不谋而合”",
    "href": "http://stock.jrj.com.cn/2020/02/03104128752076.shtml",
    "datetime": "2020-02-03 10:41:39",
    "code": "600572"
  },
  {
    "title": "康恩贝：累计捐赠50多吨医用酒精和若干口罩等疫情防控用品",
    "href": "http://stock.jrj.com.cn/2020/02/02215428749497.shtml",
    "datetime": "2020-02-02 21:54:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：1月26日正式恢复了金笛产品的生产",
    "href": "http://stock.jrj.com.cn/2020/01/27131828737597.shtml",
    "datetime": "2020-01-27 13:18:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：政策利空致2019年预亏 轻装上阵有望实现逆转",
    "href": "http://stock.jrj.com.cn/2020/01/23114028726958.shtml",
    "datetime": "2020-01-23 11:40:26",
    "code": "600572"
  },
  {
    "title": "康恩贝：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/23075028725515.shtml",
    "datetime": "2020-01-23 07:50:03",
    "code": "600572"
  },
  {
    "title": "康恩贝：2019年年度业绩预亏公告",
    "href": "http://stock.jrj.com.cn/2020/01/23010028723592.shtml",
    "datetime": "2020-01-23 01:00:28",
    "code": "600572"
  },
  {
    "title": "康恩贝：九届董事会2020年第一次临时会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/01/23010028723591.shtml",
    "datetime": "2020-01-23 01:00:28",
    "code": "600572"
  },
  {
    "title": "康恩贝2019年净利亏损2亿元至2.9亿元间",
    "href": "http://stock.jrj.com.cn/2020/01/22223828723141.shtml",
    "datetime": "2020-01-22 22:38:08",
    "code": "600572"
  },
  {
    "title": "康恩贝预亏 主业尚平稳",
    "href": "http://stock.jrj.com.cn/2020/01/22215728722978.shtml",
    "datetime": "2020-01-22 21:57:34",
    "code": "600572"
  },
  {
    "title": "商誉减值致首亏 康恩贝力争2020年实现转折",
    "href": "http://stock.jrj.com.cn/2020/01/22213128722868.shtml",
    "datetime": "2020-01-22 21:31:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：2019年度预亏2亿-2.9亿元",
    "href": "http://stock.jrj.com.cn/2020/01/22181228721751.shtml",
    "datetime": "2020-01-22 18:12:03",
    "code": "600572"
  },
  {
    "title": "康恩贝：2019年净利预亏2亿元至2.9亿元",
    "href": "http://stock.jrj.com.cn/2020/01/22175828721684.shtml",
    "datetime": "2020-01-22 17:58:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：子公司泡腾片21日销量是正常日均的3倍 vc类产品销量3万瓶",
    "href": "http://stock.jrj.com.cn/2020/01/22110728719618.shtml",
    "datetime": "2020-01-22 11:07:00",
    "code": "600572"
  },
  {
    "title": "康恩贝及公司下属子公司收到政府补助8604万元",
    "href": "http://stock.jrj.com.cn/2020/01/20214628708238.shtml",
    "datetime": "2020-01-20 21:46:03",
    "code": "600572"
  },
  {
    "title": "康恩贝子公司参加第二批全国药品集中采购拟中标",
    "href": "http://stock.jrj.com.cn/2020/01/18101828696213.shtml",
    "datetime": "2020-01-18 10:18:50",
    "code": "600572"
  },
  {
    "title": "康恩贝：控股子公司药品拟中标第二批全国药品集中采购",
    "href": "http://stock.jrj.com.cn/2020/01/17201028694661.shtml",
    "datetime": "2020-01-17 20:10:33",
    "code": "600572"
  },
  {
    "title": "康恩贝：子公司药品拟中标第二批全国药品集中采购",
    "href": "http://stock.jrj.com.cn/2020/01/17184128694016.shtml",
    "datetime": "2020-01-17 18:41:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：九届董事会2019年第十四次临时会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/12/31005028606313.shtml",
    "datetime": "2019-12-31 00:50:02",
    "code": "600572"
  },
  {
    "title": "康恩贝2.2亿转让嘉和生物股权收益4700万 财务费用同比增六成",
    "href": "http://stock.jrj.com.cn/2019/12/20102628561266.shtml",
    "datetime": "2019-12-20 10:26:37",
    "code": "600572"
  },
  {
    "title": "康恩贝：九届董事会2019年第十三次临时会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/12/18010028548215.shtml",
    "datetime": "2019-12-18 01:00:19",
    "code": "600572"
  },
  {
    "title": "康恩贝拟5000万元获得喜鹊医药约5.7%股权",
    "href": "http://stock.jrj.com.cn/2019/12/17201828547571.shtml",
    "datetime": "2019-12-17 20:18:34",
    "code": "600572"
  },
  {
    "title": "康恩贝：拟5000万元获得喜鹊医药约5.7%股权",
    "href": "http://stock.jrj.com.cn/2019/12/17192528547240.shtml",
    "datetime": "2019-12-17 19:25:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：拟5000万元增资入股喜鹊医药",
    "href": "http://stock.jrj.com.cn/2019/12/17191128547193.shtml",
    "datetime": "2019-12-17 19:11:18",
    "code": "600572"
  },
  {
    "title": "康恩贝控股股东康恩贝集团质押3530万股 用于置换前一笔融资",
    "href": "http://stock.jrj.com.cn/2019/12/05215928495954.shtml",
    "datetime": "2019-12-05 21:59:31",
    "code": "600572"
  },
  {
    "title": "康恩贝：子公司拟3520万元向关联方采购工业大麻花叶原料",
    "href": "http://stock.jrj.com.cn/2019/11/18224028415019.shtml",
    "datetime": "2019-11-18 22:40:58",
    "code": "600572"
  },
  {
    "title": "康恩贝：子公司拟向关联方采购工业大麻花叶原料",
    "href": "http://stock.jrj.com.cn/2019/11/18223328415017.shtml",
    "datetime": "2019-11-18 22:33:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：子公司拟向关联方采购工业大麻花叶原料 合同金额为3520万元",
    "href": "http://stock.jrj.com.cn/2019/11/18221728414976.shtml",
    "datetime": "2019-11-18 22:17:16",
    "code": "600572"
  },
  {
    "title": "康恩贝：已获工业大麻加工许可证 拟向关联方采购加工原料",
    "href": "http://stock.jrj.com.cn/2019/11/18220828414952.shtml",
    "datetime": "2019-11-18 22:08:00",
    "code": "600572"
  },
  {
    "title": "3分钟拉至涨停收盘暴跌5% 大资金狂砸这只工业大麻股",
    "href": "http://stock.jrj.com.cn/2019/11/12205728389941.shtml",
    "datetime": "2019-11-12 20:57:44",
    "code": "600572"
  },
  {
    "title": "数据复盘｜6股主力资金净流入超亿元 康恩贝遭机构卖出逾1亿元",
    "href": "http://stock.jrj.com.cn/invest/2019/11/12181628389048.shtml",
    "datetime": "2019-11-12 18:16:00",
    "code": "600572"
  },
  {
    "title": "康恩贝跌逾5% 一家机构卖出1.39亿元",
    "href": "http://stock.jrj.com.cn/2019/11/12164328388605.shtml",
    "datetime": "2019-11-12 16:43:00",
    "code": "600572"
  },
  {
    "title": "工业大麻“利好”来去匆匆 康恩贝股价跌5.16%",
    "href": "http://stock.jrj.com.cn/2019/11/12162528388487.shtml",
    "datetime": "2019-11-12 16:25:13",
    "code": "600572"
  },
  {
    "title": "康恩贝双十一电商全平台合计销售同比增长21%",
    "href": "http://stock.jrj.com.cn/2019/11/12152628388216.shtml",
    "datetime": "2019-11-12 15:26:00",
    "code": "600572"
  },
  {
    "title": "康恩贝股价直线拉升涨超9%",
    "href": "http://stock.jrj.com.cn/2019/11/12133328387442.shtml",
    "datetime": "2019-11-12 13:33:00",
    "code": "600572"
  },
  {
    "title": "[独家]康恩贝全资子公司获工业大麻花叶加工许可证",
    "href": "http://stock.jrj.com.cn/2019/11/12132828387441.shtml",
    "datetime": "2019-11-12 13:28:00",
    "code": "600572"
  },
  {
    "title": "康恩贝全资子公司获工业大麻花叶加工许可证",
    "href": "http://stock.jrj.com.cn/2019/11/12132628387408.shtml",
    "datetime": "2019-11-12 13:26:44",
    "code": "600572"
  },
  {
    "title": "康恩贝前三季度盈利4.74亿 同比下滑39%",
    "href": "http://stock.jrj.com.cn/2019/10/31103328331951.shtml",
    "datetime": "2019-10-31 10:33:42",
    "code": "600572"
  },
  {
    "title": "康恩贝：2019年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/10/31015028329256.shtml",
    "datetime": "2019-10-31 01:50:11",
    "code": "600572"
  },
  {
    "title": "康恩贝：九届董事会2019年第十次临时会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/10/31015028329255.shtml",
    "datetime": "2019-10-31 01:50:11",
    "code": "600572"
  },
  {
    "title": "康恩贝：发力多品牌优势 让挫折变转折",
    "href": "http://stock.jrj.com.cn/2019/10/30222028328477.shtml",
    "datetime": "2019-10-30 22:20:00",
    "code": "600572"
  },
  {
    "title": "康麻日化落户杭州 康恩贝集团工业大麻版图添新丁",
    "href": "http://stock.jrj.com.cn/2019/10/21174728277929.shtml",
    "datetime": "2019-10-21 17:47:00",
    "code": "600572"
  },
  {
    "title": "国内工业进入应用阶段 康恩贝即将推出眼膜",
    "href": "http://stock.jrj.com.cn/2019/09/28034628194132.shtml",
    "datetime": "2019-09-28 03:46:49",
    "code": "600572"
  },
  {
    "title": "国内工业大麻产业进入应用阶段 康恩贝即将推出大麻眼膜",
    "href": "http://stock.jrj.com.cn/2019/09/27135128190813.shtml",
    "datetime": "2019-09-27 13:51:00",
    "code": "600572"
  },
  {
    "title": "康恩贝控股股东康恩贝集团质押7250万股用于贷款融资担保",
    "href": "http://stock.jrj.com.cn/2019/09/20221528161876.shtml",
    "datetime": "2019-09-20 22:15:28",
    "code": "600572"
  },
  {
    "title": "康恩贝：2016年公司债券2019年付息公告",
    "href": "http://stock.jrj.com.cn/2019/09/18233028150384.shtml",
    "datetime": "2019-09-18 23:30:00",
    "code": "600572"
  },
  {
    "title": "【康恩贝】大幅拉升-0.28% 股价创近2个月新高",
    "href": "http://stock.jrj.com.cn/2019/09/17095128138844.shtml",
    "datetime": "2019-09-17 09:51:57",
    "code": "600572"
  },
  {
    "title": "【康恩贝】大幅拉升3.35% 股价创近2个月新高",
    "href": "http://stock.jrj.com.cn/2019/09/16112228134062.shtml",
    "datetime": "2019-09-16 11:22:33",
    "code": "600572"
  },
  {
    "title": "康恩贝高级管理人员辞职 2019年上半年净利同比减少30%",
    "href": "http://stock.jrj.com.cn/2019/08/22105228015448.shtml",
    "datetime": "2019-08-22 10:52:10",
    "code": "600572"
  },
  {
    "title": "康恩贝：2019年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/08/22000028013229.shtml",
    "datetime": "2019-08-22 00:00:11",
    "code": "600572"
  },
  {
    "title": "康恩贝：九届董事会第六次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/08/22000028013228.shtml",
    "datetime": "2019-08-22 00:00:11",
    "code": "600572"
  },
  {
    "title": "康恩贝5个药品新增调入新版医保目录 7个药品调整医保分类",
    "href": "http://stock.jrj.com.cn/2019/08/21201328012491.shtml",
    "datetime": "2019-08-21 20:13:29",
    "code": "600572"
  },
  {
    "title": "康恩贝：5个药品新增调入新版医保目录 7个药品调整医保分类",
    "href": "http://stock.jrj.com.cn/2019/08/21195328012429.shtml",
    "datetime": "2019-08-21 19:53:36",
    "code": "600572"
  },
  {
    "title": "康恩贝：5个药品新增调入新版医保目录 7个药品调整医保分类",
    "href": "http://stock.jrj.com.cn/2019/08/21194728012417.shtml",
    "datetime": "2019-08-21 19:47:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：上半年净利3.9亿元 同比下降30%",
    "href": "http://stock.jrj.com.cn/2019/08/21192128012294.shtml",
    "datetime": "2019-08-21 19:21:49",
    "code": "600572"
  },
  {
    "title": "康恩贝2019年上半年净利3.9亿 销售整体保持稳定",
    "href": "http://stock.jrj.com.cn/2019/08/21175928011927.shtml",
    "datetime": "2019-08-21 17:59:13",
    "code": "600572"
  },
  {
    "title": "康恩贝上半年净利同比降29.54%",
    "href": "http://stock.jrj.com.cn/2019/08/21172328011199.shtml",
    "datetime": "2019-08-21 17:23:08",
    "code": "600572"
  },
  {
    "title": "康恩贝：上半年净利同比降29.54%",
    "href": "http://stock.jrj.com.cn/2019/08/21172028011178.shtml",
    "datetime": "2019-08-21 17:20:00",
    "code": "600572"
  },
  {
    "title": "康恩贝集团：目标成为国内最大的CBD提取物供应商",
    "href": "http://stock.jrj.com.cn/2019/08/15135327981145.shtml",
    "datetime": "2019-08-15 13:53:00",
    "code": "600572"
  },
  {
    "title": "康恩贝集团：正对工业大麻进行基础性研究和全产业链布局",
    "href": "http://stock.jrj.com.cn/2019/08/15134627981093.shtml",
    "datetime": "2019-08-15 13:46:11",
    "code": "600572"
  },
  {
    "title": "康恩贝集团董事长：工业大麻产业若仅停留在前端环节经营风险极大",
    "href": "http://stock.jrj.com.cn/2019/08/15104527980411.shtml",
    "datetime": "2019-08-15 10:45:10",
    "code": "600572"
  },
  {
    "title": "康恩贝集团胡季强：工业大麻产业若仅停留在前端环节经营风险极大",
    "href": "http://stock.jrj.com.cn/2019/08/15104327980444.shtml",
    "datetime": "2019-08-15 10:43:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：2019年第二次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/08/13004027964643.shtml",
    "datetime": "2019-08-13 00:40:14",
    "code": "600572"
  },
  {
    "title": "康恩贝：已累计回购3.65%股份 耗资5.85亿元",
    "href": "http://stock.jrj.com.cn/2019/08/01214227917461.shtml",
    "datetime": "2019-08-01 21:42:24",
    "code": "600572"
  },
  {
    "title": "[哈药股份]9.53亿元,康恩贝官宣支持嘉和生物实现上市",
    "href": "http://stock.jrj.com.cn/2019/07/31000027909399.shtml",
    "datetime": "2019-07-31 00:00:00",
    "code": "600572"
  },
  {
    "title": "康恩贝股东博康医药质押575万股 公司去年净利同比增长13%",
    "href": "http://stock.jrj.com.cn/2019/07/19074927864941.shtml",
    "datetime": "2019-07-19 07:49:08",
    "code": "600572"
  },
  {
    "title": "康恩贝：九届董事会2019年第八次临时会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/06/26013027755332.shtml",
    "datetime": "2019-06-26 01:30:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：拟9.5亿元认购JHBP股份",
    "href": "http://stock.jrj.com.cn/2019/06/25215827754856.shtml",
    "datetime": "2019-06-25 21:58:56",
    "code": "600572"
  },
  {
    "title": "日均1164场学术活动怎么开展？ 康恩贝回应：可2人每场",
    "href": "http://stock.jrj.com.cn/2019/06/20150727731219.shtml",
    "datetime": "2019-06-20 15:07:08",
    "code": "600572"
  },
  {
    "title": "[天眼]康恩贝工业大麻信息披露随意遭监管 资金追捧告一段落股价过山车",
    "href": "http://stock.jrj.com.cn/2019/06/19213527726735.shtml",
    "datetime": "2019-06-19 21:35:42",
    "code": "600572"
  },
  {
    "title": "康恩贝：2.4万亩工业大麻种植完成",
    "href": "http://stock.jrj.com.cn/2019/06/19133727724557.shtml",
    "datetime": "2019-06-19 13:37:17",
    "code": "600572"
  },
  {
    "title": "康恩贝回复年报问询函：销售费用增加与营销模式转型有关",
    "href": "http://stock.jrj.com.cn/2019/06/19092627723476.shtml",
    "datetime": "2019-06-19 09:26:00",
    "code": "600572"
  },
  {
    "title": "康恩贝延迟回复问询 千亿目标执行力仅7%",
    "href": "http://stock.jrj.com.cn/2019/06/13075627697695.shtml",
    "datetime": "2019-06-13 07:56:11",
    "code": "600572"
  },
  {
    "title": "康恩贝：全资子公司药品通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2019/06/10184327681687.shtml",
    "datetime": "2019-06-10 18:43:50",
    "code": "600572"
  },
  {
    "title": "康恩贝：子公司药品通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2019/06/10183727681675.shtml",
    "datetime": "2019-06-10 18:37:00",
    "code": "600572"
  },
  {
    "title": "一季报负增长成定论 康恩贝财报指标背离上交所问询",
    "href": "http://stock.jrj.com.cn/2019/06/10164627681235.shtml",
    "datetime": "2019-06-10 16:46:35",
    "code": "600572"
  },
  {
    "title": "康恩贝控股股东康恩贝集团质押6700万股 去年营收同比增长28%",
    "href": "http://stock.jrj.com.cn/2019/06/05075927665732.shtml",
    "datetime": "2019-06-05 07:59:07",
    "code": "600572"
  },
  {
    "title": "康恩贝：九届董事会2019年第七次临时会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/06/01002027649825.shtml",
    "datetime": "2019-06-01 00:20:05",
    "code": "600572"
  },
  {
    "title": "康恩贝9.52亿投资亏损超2000万 子公司珍视明业绩“神话”被问询",
    "href": "http://stock.jrj.com.cn/2019/05/30103027640881.shtml",
    "datetime": "2019-05-30 10:30:00",
    "code": "600572"
  },
  {
    "title": "康恩贝9.52亿投资亏损超2000万 子公司珍视明业绩“神话”被问询",
    "href": "http://stock.jrj.com.cn/2019/05/30103027661365.shtml",
    "datetime": "2019-05-30 10:30:00",
    "code": "600572"
  },
  {
    "title": "康恩贝控股股东康恩贝集团质押3360万股 去年营收同比增长28%",
    "href": "http://stock.jrj.com.cn/2019/05/08072727540741.shtml",
    "datetime": "2019-05-08 07:27:52",
    "code": "600572"
  },
  {
    "title": "康恩贝一季度净利1.76亿同比下滑34% 现金流量净额为2亿元",
    "href": "http://stock.jrj.com.cn/2019/04/26064727487119.shtml",
    "datetime": "2019-04-26 06:47:48",
    "code": "600572"
  },
  {
    "title": "康恩贝年报业绩创新高 集团工业大麻已种植面积达4000余亩",
    "href": "http://stock.jrj.com.cn/2019/04/26032627485333.shtml",
    "datetime": "2019-04-26 03:26:51",
    "code": "600572"
  },
  {
    "title": "康恩贝去年净利8亿元 同比增长13% 董事长胡季强薪酬30万元",
    "href": "http://stock.jrj.com.cn/2019/04/25183527483074.shtml",
    "datetime": "2019-04-25 18:35:55",
    "code": "600572"
  },
  {
    "title": "康恩贝：2018年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/04/25075027479040.shtml",
    "datetime": "2019-04-25 07:50:19",
    "code": "600572"
  },
  {
    "title": "康恩贝：2019年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/04/25075027479042.shtml",
    "datetime": "2019-04-25 07:50:19",
    "code": "600572"
  },
  {
    "title": "康恩贝：关于召开2018年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2019/04/25075027479043.shtml",
    "datetime": "2019-04-25 07:50:19",
    "code": "600572"
  },
  {
    "title": "康恩贝：九届董事会第五次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/04/25075027479041.shtml",
    "datetime": "2019-04-25 07:50:19",
    "code": "600572"
  },
  {
    "title": "康恩贝：2018年净利同比增长13% 拟10派1.5元",
    "href": "http://stock.jrj.com.cn/2019/04/24213427476377.shtml",
    "datetime": "2019-04-24 21:34:54",
    "code": "600572"
  },
  {
    "title": "康恩贝：一季度净利1.76亿元 同比下降34%",
    "href": "http://stock.jrj.com.cn/2019/04/24213027476373.shtml",
    "datetime": "2019-04-24 21:30:56",
    "code": "600572"
  },
  {
    "title": "康恩贝：工业大麻试制预计3到5个月内完成",
    "href": "http://stock.jrj.com.cn/2019/04/08024427340560.shtml",
    "datetime": "2019-04-08 02:44:31",
    "code": "600572"
  },
  {
    "title": "康恩贝工业大麻产业有优势",
    "href": "http://stock.jrj.com.cn/2019/04/07200227341318.shtml",
    "datetime": "2019-04-07 20:02:21",
    "code": "600572"
  },
  {
    "title": "康恩贝：工业大麻生产工艺改造试制预计3到5个月内完成",
    "href": "http://stock.jrj.com.cn/2019/04/07194627340229.shtml",
    "datetime": "2019-04-07 19:46:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：希康生物的三家子公司即将结合农时等情况播种工业大麻种子",
    "href": "http://stock.jrj.com.cn/2019/04/04140427320652.shtml",
    "datetime": "2019-04-04 14:04:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：拟3000万元参与设立康麻生物",
    "href": "http://stock.jrj.com.cn/2019/03/28204927260748.shtml",
    "datetime": "2019-03-28 20:49:06",
    "code": "600572"
  },
  {
    "title": "龙虎榜：工业大麻概念股康恩贝跌停 北向资金资金逆市抢筹",
    "href": "http://stock.jrj.com.cn/2019/03/28173027259521.shtml",
    "datetime": "2019-03-28 17:30:00",
    "code": "600572"
  },
  {
    "title": "全国人大代表、康恩贝董事长胡季强：推广兰溪经验 促进传统制造业高质量发展",
    "href": "http://stock.jrj.com.cn/2019/03/12145227154094.shtml",
    "datetime": "2019-03-12 14:52:51",
    "code": "600572"
  },
  {
    "title": "康恩贝：工业大麻种植业务与公司无直接关系 子公司尚未种植",
    "href": "http://stock.jrj.com.cn/2019/03/11185827147819.shtml",
    "datetime": "2019-03-11 18:58:45",
    "code": "600572"
  },
  {
    "title": "康恩贝：工业大麻种植业务与公司无直接相关关系",
    "href": "http://stock.jrj.com.cn/2019/03/11185527147814.shtml",
    "datetime": "2019-03-11 18:55:23",
    "code": "600572"
  },
  {
    "title": "康恩贝胡季强：建议优化国家基本医疗保障药品目录及动态调整机制",
    "href": "http://stock.jrj.com.cn/2019/03/09120227138999.shtml",
    "datetime": "2019-03-09 12:02:00",
    "code": "600572"
  },
  {
    "title": "康恩贝拟对旗下公司追投9000万 推动后者向工业大麻产业转型",
    "href": "http://stock.jrj.com.cn/2019/03/08200927137844.shtml",
    "datetime": "2019-03-08 20:09:38",
    "code": "600572"
  },
  {
    "title": "全国人大代表、康恩贝胡季强：建议明确电煤水汽价格随增值税率下降同步下调",
    "href": "http://stock.jrj.com.cn/2019/03/07171627132041.shtml",
    "datetime": "2019-03-07 17:16:09",
    "code": "600572"
  },
  {
    "title": "康恩贝：九届董事会2019年第四次临时会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/03/01231027107843.shtml",
    "datetime": "2019-03-01 23:10:00",
    "code": "600572"
  },
  {
    "title": "在云南获得2.4万亩工业大麻种植许可 康恩贝涨停",
    "href": "http://stock.jrj.com.cn/2019/02/21094027069877.shtml",
    "datetime": "2019-02-21 09:40:18",
    "code": "600572"
  },
  {
    "title": "康恩贝开盘涨停 康恩贝集团获2.4万亩工业大麻种植许可",
    "href": "http://stock.jrj.com.cn/2019/02/21093027069857.shtml",
    "datetime": "2019-02-21 09:30:00",
    "code": "600572"
  },
  {
    "title": "康恩贝集团在云南获得2.4万亩工业大麻种植许可",
    "href": "http://stock.jrj.com.cn/2019/02/20220827068170.shtml",
    "datetime": "2019-02-20 22:08:00",
    "code": "600572"
  },
  {
    "title": "康恩贝控股股东康恩贝集团质押3650万股 其所持51%被质押",
    "href": "http://stock.jrj.com.cn/2019/02/16181227050378.shtml",
    "datetime": "2019-02-16 18:12:38",
    "code": "600572"
  },
  {
    "title": "康恩贝：已累计回购3.65%股份 耗资5.85亿元",
    "href": "http://stock.jrj.com.cn/hotstock/2019/02/12080027032690.shtml",
    "datetime": "2019-02-12 08:00:02",
    "code": "600572"
  },
  {
    "title": "近60家公司披露回购进展 康恩贝回购金额近6亿",
    "href": "http://stock.jrj.com.cn/invest/2019/02/12063127032595.shtml",
    "datetime": "2019-02-12 06:31:00",
    "code": "600572"
  },
  {
    "title": "30家公司披露回购进展 康恩贝回购金额已近6亿元",
    "href": "http://stock.jrj.com.cn/2019/02/11185527029125.shtml",
    "datetime": "2019-02-11 18:55:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：已耗资5.85亿元回购3.65%股份",
    "href": "http://stock.jrj.com.cn/2019/02/11155727028499.shtml",
    "datetime": "2019-02-11 15:57:00",
    "code": "600572"
  },
  {
    "title": "康恩贝赶上热点 加工大麻花叶项目获批",
    "href": "http://stock.jrj.com.cn/2019/01/27202026987763.shtml",
    "datetime": "2019-01-27 20:20:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：二级全资子公司加工大麻花叶项目申请获批复",
    "href": "http://stock.jrj.com.cn/2019/01/27171226987300.shtml",
    "datetime": "2019-01-27 17:12:45",
    "code": "600572"
  },
  {
    "title": "金圆股份：康恩贝集团协议转让公司5.01%股份",
    "href": "http://stock.jrj.com.cn/2019/01/07190926867930.shtml",
    "datetime": "2019-01-07 19:09:49",
    "code": "600572"
  },
  {
    "title": "康恩贝：非公开发行限售股上市流通公告",
    "href": "http://stock.jrj.com.cn/2019/01/04222026854876.shtml",
    "datetime": "2019-01-04 22:20:05",
    "code": "600572"
  },
  {
    "title": "康恩贝：2019年第一次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/01/03232026849170.shtml",
    "datetime": "2019-01-03 23:20:03",
    "code": "600572"
  },
  {
    "title": "康恩贝：拟上调回购金额",
    "href": "http://stock.jrj.com.cn/2018/12/17215526756184.shtml",
    "datetime": "2018-12-17 21:55:22",
    "code": "600572"
  },
  {
    "title": "康恩贝：回购股份额拟调整为4亿至8亿元",
    "href": "http://stock.jrj.com.cn/2018/12/17182626755394.shtml",
    "datetime": "2018-12-17 18:26:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：已累计回购1.05%股份 耗资1.75亿元",
    "href": "http://stock.jrj.com.cn/hotstock/2018/12/04075925446148.shtml",
    "datetime": "2018-12-04 07:59:58",
    "code": "600572"
  },
  {
    "title": "康恩贝董事长胡季强：专注制药、专业制药",
    "href": "http://stock.jrj.com.cn/2018/11/14063025342700.shtml",
    "datetime": "2018-11-14 06:30:00",
    "code": "600572"
  },
  {
    "title": "康恩贝股东康恩贝集团质押400万股 占公司总股本的0.15%",
    "href": "http://stock.jrj.com.cn/2018/11/13132125339081.shtml",
    "datetime": "2018-11-13 13:21:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：员工持股计划出售完毕",
    "href": "http://stock.jrj.com.cn/2018/11/12164725333891.shtml",
    "datetime": "2018-11-12 16:47:00",
    "code": "600572"
  },
  {
    "title": "康恩贝股东康恩贝集团质押1556万股 占公司总股本的0.58%",
    "href": "http://stock.jrj.com.cn/2018/11/06143625310621.shtml",
    "datetime": "2018-11-06 14:36:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：小儿碳酸钙D3颗粒获注册批件",
    "href": "http://stock.jrj.com.cn/hotstock/2018/11/06080025308961.shtml",
    "datetime": "2018-11-06 08:00:00",
    "code": "600572"
  },
  {
    "title": "康恩贝小儿碳酸钙D3颗粒获注册批件",
    "href": "http://stock.jrj.com.cn/2018/11/05180625307087.shtml",
    "datetime": "2018-11-05 18:06:52",
    "code": "600572"
  },
  {
    "title": "康恩贝：已累计回购1218万股 耗资逾7500万元",
    "href": "http://stock.jrj.com.cn/hotstock/2018/11/02080025295777.shtml",
    "datetime": "2018-11-02 08:00:02",
    "code": "600572"
  },
  {
    "title": "康恩贝公布股份回购进展：回购逾7500万元股份",
    "href": "http://stock.jrj.com.cn/2018/11/01171025293524.shtml",
    "datetime": "2018-11-01 17:10:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：已回购逾7500万元股份",
    "href": "http://stock.jrj.com.cn/2018/11/01170325293504.shtml",
    "datetime": "2018-11-01 17:03:00",
    "code": "600572"
  },
  {
    "title": "康恩贝发布第三季度报告 营业收入较上年同期增长42.57%",
    "href": "http://stock.jrj.com.cn/2018/10/29113925271610.shtml",
    "datetime": "2018-10-29 11:39:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：2018年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/10/29082025270599.shtml",
    "datetime": "2018-10-29 08:20:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：九届董事会2018年第十二次临时会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/10/29082025270600.shtml",
    "datetime": "2018-10-29 08:20:00",
    "code": "600572"
  },
  {
    "title": "[康恩贝]康恩贝前三季营收净利超去年全年 证金公司持股增至4.38%",
    "href": "http://stock.jrj.com.cn/2018/10/29000025272818.shtml",
    "datetime": "2018-10-29 00:00:00",
    "code": "600572"
  },
  {
    "title": "康恩贝前三季营收净利均超去年全年 证金公司持股增至4.38%",
    "href": "http://stock.jrj.com.cn/2018/10/28202325269724.shtml",
    "datetime": "2018-10-28 20:23:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：前三季度净利润同比增长26.27％",
    "href": "http://stock.jrj.com.cn/2018/10/28143425268702.shtml",
    "datetime": "2018-10-28 14:34:29",
    "code": "600572"
  },
  {
    "title": "康恩贝：前三季度净利7.67亿元 同比增26%",
    "href": "http://stock.jrj.com.cn/2018/10/28143325268704.shtml",
    "datetime": "2018-10-28 14:33:00",
    "code": "600572"
  },
  {
    "title": "康恩贝：拟9.6亿元设立全资子公司上海康嘉",
    "href": "http://stock.jrj.com.cn/hotstock/2018/10/23082925244533.shtml",
    "datetime": "2018-10-23 08:29:58",
    "code": "600572"
  },
  {
    "title": "康恩贝：九届董事会2018年第十一次临时会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/10/22212025239420.shtml",
    "datetime": "2018-10-22 21:20:01",
    "code": "600572"
  },
  {
    "title": "康恩贝拟9.6亿设子公司助力参股公司嘉和生物境外上市",
    "href": "http://stock.jrj.com.cn/2018/10/22201425239160.shtml",
    "datetime": "2018-10-22 20:14:12",
    "code": "600572"
  },
  {
    "title": "康恩贝：拟9.6亿元设立子公司 助力参股公司嘉和生物境外上市",
    "href": "http://stock.jrj.com.cn/2018/10/22190025240558.shtml",
    "datetime": "2018-10-22 19:00:00",
    "code": "600572"
  },
  {
    "title": "[康恩贝]从原点出发,以不竭诚爱担生命之托!",
    "href": "http://stock.jrj.com.cn/2018/10/22000025238444.shtml",
    "datetime": "2018-10-22 00:00:00",
    "code": "600572"
  }
]